STAAR Surgical (STAA) holder reports 6.5% stake, board appointment

Rhea-AI Filing Summary

STAAR Surgical Co received an updated ownership filing from a group of investment entities connected to Yunqi and HS Group. The largest reported position is 3,257,130 shares of common stock, representing 6.5% of the class, beneficially owned by Yunqi Capital Limited, Yunqi Capital Cayman Limited, Christopher Min Fang Wang, and related entities. Other entities in the group, including Yunqi Path Capital Master Fund and Yunqi China Special Investment A, report additional share holdings, with Yunqi Path Capital Master Fund alone reporting 2,575,061 shares, or 5.2% of the class. The amendment also notes that on January 14, 2026, STAAR Surgical entered into a cooperation agreement with Broadwood Partners, L.P., under which Christopher Min Fang Wang was appointed to the company’s Board of Directors effective that same date.

Insights

Equity ownership and governance analyst

A 6.5% holder gains board representation at STAAR Surgical.

STAAR Surgical is now reporting a coordinated group of investment entities, led by Yunqi Capital, with beneficial ownership of up to 3,257,130 shares, or 6.5% of its common stock. Another vehicle within the group, Yunqi Path Capital Master Fund, reports 2,575,061 shares, equal to 5.2% of the class.

The filing also notes a cooperation agreement between STAAR Surgical and Broadwood Partners, L.P., under which Christopher Min Fang Wang has been appointed to the Board of Directors as of January 14, 2026. This links a sizable shareholder group with direct board-level influence.

From an investor perspective, the combination of a >5% ownership position and a board seat can shape discussions on strategy and capital allocation. Future company communications and governance disclosures after January 14, 2026 will reflect this new board composition.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 7)

STAAR SURGICAL CO

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

852312305

(CUSIP Number)

Christopher Min Fang Wang
Unit 3703, 37/F AIA Tower, 183 Electric Road, North Point
Hong Kong, K3, 00000
852 37933457

Andrew Freedman, Esq.
Olshan Frome Wolosky LLP, 1325 Avenue of the Americas
New York, NY, 10019
212-451-2300

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

01/14/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 852312305

1

Name of reporting person

Yunqi Path Capital Master Fund

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 2,575,061.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 2,575,061.00

11

Aggregate amount beneficially owned by each reporting person

2,575,061.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.2 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP No. 852312305

1

Name of reporting person

Yunqi Capital Limited

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

HONG KONG

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 3,257,130.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 3,257,130.00

11

Aggregate amount beneficially owned by each reporting person

3,257,130.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

6.5 %

14

Type of Reporting Person (See Instructions)

CO, IA

SCHEDULE 13D

CUSIP No. 852312305

1

Name of reporting person

Yunqi Capital Cayman Limited

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 3,257,130.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 3,257,130.00

11

Aggregate amount beneficially owned by each reporting person

3,257,130.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

6.5 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP No. 852312305

1

Name of reporting person

Christopher Min Fang Wang

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CANADA (FEDERAL LEVEL)

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 3,257,130.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 3,257,130.00

11

Aggregate amount beneficially owned by each reporting person

3,257,130.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

6.5 %

14

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13D

CUSIP No. 852312305

1

Name of reporting person

Yunqi China Special Investment A

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 682,069.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 682,069.00

11

Aggregate amount beneficially owned by each reporting person

682,069.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

1.4 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP No. 852312305

1

Name of reporting person

HS Group Master Fund II Ltd

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 682,069.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 682,069.00

11

Aggregate amount beneficially owned by each reporting person

682,069.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

1.4 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP No. 852312305

1

Name of reporting person

HS Group (Hong Kong) Limited

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

HONG KONG

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 682,069.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 682,069.00

11

Aggregate amount beneficially owned by each reporting person

682,069.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

1.4 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP No. 852312305

1

Name of reporting person

HS Group Ltd

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 682,069.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 682,069.00

11

Aggregate amount beneficially owned by each reporting person

682,069.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

1.4 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, par value $0.01 per share
(b)	Name of Issuer: STAAR SURGICAL CO
(c)	Address of Issuer's Principal Executive Offices: 1911 WALKER AVE, MONROVIA, CALIFORNIA , 91016.
Item 1 Comment: This Amendment No. 7 amends the statement on Schedule 13D filed by Yunqi Capital Limited and other Reporting Persons on September 22, 2025, as amended on October 7, 2025, October 21, 2025, October 27, 2025, November 3, 2025, December 11, 2025 and January 8, 2026 (the "Schedule 13D").
Item 4.	Purpose of Transaction
	On January 14, 2026, the Issuer entered into a letter agreement (the "Cooperation Agreement") with Broadwood Partners, L.P. pursuant to which the Issuer agreed, among other things, to appoint Christopher Min Fang Wang to its Board of Directors, effective as of the date of the Cooperation Agreement.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Yunqi Path Capital Master Fund

Signature:	/s/ Christopher Min Fang Wang
Name/Title:	Christopher Min Fang Wang / Director
Date:	01/16/2026

Yunqi Capital Limited

Signature:	/s/ Christopher Min Fang Wang
Name/Title:	Christopher Min Fang Wang / Director
Date:	01/16/2026

Yunqi Capital Cayman Limited

Signature:	/s/ Christopher Min Fang Wang
Name/Title:	Christopher Min Fang Wang / Director
Date:	01/16/2026

Christopher Min Fang Wang

Signature:	/s/ Christopher Min Fang Wang
Name/Title:	Christopher Min Fang Wang
Date:	01/16/2026

Yunqi China Special Investment A

Signature:	/s/ Christopher Min Fang Wang
Name/Title:	Christopher Min Fang Wang / Director
Date:	01/16/2026

HS Group Master Fund II Ltd

Signature:	/s/ Michael Garrow
Name/Title:	Michael Garrow / Director
Date:	01/16/2026

HS Group (Hong Kong) Limited

Signature:	/s/ Michael Garrow
Name/Title:	Michael Garrow / Director
Date:	01/16/2026

HS Group Ltd

Signature:	/s/ Michael Garrow
Name/Title:	Michael Garrow / Director
Date:	01/16/2026

FAQ

What percentage of STAAR Surgical (STAA) shares does Yunqi Capital report owning?

Yunqi Capital Limited, together with Yunqi Capital Cayman Limited and Christopher Min Fang Wang, reports beneficial ownership of 3,257,130 shares of STAAR Surgical common stock, representing 6.5% of the class.

How many STAAR Surgical shares does Yunqi Path Capital Master Fund hold?

Yunqi Path Capital Master Fund reports beneficial ownership of 2,575,061 shares of STAAR Surgical common stock, which the filing states is 5.2% of the outstanding class.

Who was appointed to STAAR Surgical’s Board of Directors in this filing?

Christopher Min Fang Wang was appointed to the Board of Directors of STAAR Surgical. The filing notes this appointment became effective on January 14, 2026 under a cooperation agreement.

What agreement led to Christopher Min Fang Wang joining STAAR Surgical’s board?

The filing states that on January 14, 2026, STAAR Surgical entered into a Cooperation Agreement with Broadwood Partners, L.P., under which the company agreed, among other things, to appoint Christopher Min Fang Wang to its Board of Directors.

Which entities are included in the STAAR Surgical Schedule 13D/A reporting group?

The reporting group includes Yunqi Path Capital Master Fund, Yunqi Capital Limited, Yunqi Capital Cayman Limited, Christopher Min Fang Wang, Yunqi China Special Investment A, HS Group Master Fund II Ltd, HS Group (Hong Kong) Limited, and HS Group Ltd.

What is the purpose of this Amendment No. 7 to the STAAR Surgical Schedule 13D?

The amendment updates the previously filed Schedule 13D to reflect current beneficial ownership levels in STAAR Surgical and to disclose the cooperation agreement that resulted in Christopher Min Fang Wang’s appointment to the Board of Directors on January 14, 2026.